Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity

被引：0
|
作者：
Norbert Kociok
Tim U. Krohne
Vassiliki Poulaki
Antonia M. Joussen
机构：
[1] University of Cologne,Department of Vitreoretinal Surgery, Center for Ophthalmology
[2] University of Cologne,Center for Molecular Medicine (CMMC)
[3] Harvard Medical School,Massacussetts Eye and Ear Infirmary
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2007年 / 245卷
关键词：
Retina; Geldanamycin; Neovascularization; Retinopathy of prematurity; Kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：258 / 266
页数：8
相关论文
共 50 条
  • [31] Improvement of Retinal Neovascularization with Diltiazem in an Animal Model of Retinopathy of Prematurity † 272
    Rosemary D Higgins
    Kun Yu
    Bharat Nandgaonkar
    Tomas Rotschild
    Pediatric Research, 1998, 43 (Suppl 4) : 49 - 49
  • [32] Human opticin reduces pathological preretinal neovascularization in the mouse model of oxygen-induced retinopathy
    Klaska, Izabela Paulina
    Orr, Catherine
    White, Anne
    Alcubierre, Pilar Villacampa
    Hervas, Laura Abelleira
    Hoke, Justin
    Bunce, Catey V.
    Unwin, Richard
    Cooper, Garth
    Bishop, Paul N.
    Bainbridge, James W. B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [33] Intravitreal injection of PBS reduces retinal neovascularization in the mouse oxygen-induced retinopathy model
    Vahatupa, Maria
    Uusitalo-Jarvinen, Hannele
    Jarvinen, Tero
    Uusitalo, Hannu M. T.
    Kalesnykas, Giedrius
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [34] Comparative Spatial Profiling of Mouse Retinopathy of Prematurity (ROP) Model To Elucidate Cell -Specific Interactions In Retinal Neovascularization
    Chong, Kelvin
    Loktev, Alexander
    Roozafzoon, Reza
    Thao-Nguyen Bach
    Ximerakis, Methodios
    Wang, Xiaomeng
    Wong, Michael Thomas
    Tamburino, Alex M.
    Chia, Ser Mien
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [35] Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity
    Geisen, P.
    Peterson, L. J.
    Martiniuk, D.
    Uppal, Ahbineet
    Saito, Y.
    Hartnett, M. Elizabeth
    MOLECULAR VISION, 2008, 14 (41-43): : 345 - 357
  • [36] Retinopathy of prematurity: Is suppression of neovascularization achievable? Reply
    Johnson, L
    Quinn, GE
    Abbasi, S
    Gerdes, JS
    Bhutani, VK
    JOURNAL OF PEDIATRICS, 1996, 129 (04): : 618 - 619
  • [37] Improved Clinical Assessment of a Mouse Model of Retinopathy of Prematurity
    Zarbin, Marco
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (11) : 1461 - 1461
  • [38] Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
    Ng, Wei Loon
    Trinavarat, Adisak
    Atchaneeyasakul, La-ongsri
    BMC PEDIATRICS, 2024, 24 (01)
  • [39] Inhibition of retinal neovascularization by intravitreal herbimycin A in a rat model of retinopathy of prematurity.
    Bullard, LE
    Roberto, KA
    Ford, BL
    Penn, JS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2842 - 2842
  • [40] Inhibition of retinal neovascularization (NV) by AAV-mediated gene transfer of endostatin in a mouse model of retinopathy of prematurity (ROP)
    Deng, W
    Raisler, B
    Pang, J
    Chiodo, V
    Yan, Z
    Berns, K
    Hauswirth, W
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U111 - U111
12345